sciencevega-logo
sciencevega-logo

Concept   |   Meet the Editor   |   Publications   |   Support



Venomous crustacean provides new drug candidates

by | Oct 8, 2024 | Earth Science

The researchers collect the underwater crab Xibalbanus tulumensis, which only occurs here. Credit: Björn M von Reumont/ Goethe University Frankfurt.

Toxins from remipede crabs in from Mayan underwater caves have pharmacological potential according to new research.

Many animals use venoms for self-defence or hunting. The components of such venom, known as toxins, interfere with various physiological processes – which is also the reason why they are so interesting for the development of new pharmacological agents.

While the venoms of some animal groups – including snakes, spiders, scorpions and insects – have already been well studied, the situation is entirely different for marine animal groups.

Here, data exists only for individual animal species, meaning this group still holds great untapped potential.

It was only discovered a few years ago that there also exist venomous crustaceans, ie remipedes that look more like centipedes and live in marine underwater caves.

A multidisciplinary research team led by Dr Björn von Reumont, who first described the venom system in remipedes in 2014 and is currently a guest researcher at Goethe University Frankfurt, has now characterised a group of toxins from the Xibalbanus tulumensis remipede.

To that end, Reumont put together a team consisting of cooperation partners from Fraunhofer Institute for Translational Medicine (ITMP) within the framework of the LOEWE Center for Translational Biodiversity, as well as colleagues from the University of Leuven, from Cologne, Berlin and Munich – all of them also part of the European Venom Network (COST Action EUVEN).

Xibalbanus tulumensis contains toxins that are suitable for the development of active substances against neurological diseases. Credit: Björn M von Reumont.

Remipede

The Xibalbanus tulumensis remipede lives in the cenotes which are the underwater cave systems on the Mexican Yucatan peninsula.

The cave dweller injects the venom produced in its venom gland directly into its prey. This toxin contains a variety of components, including a new type of peptide, named xibalbine, after its crustacean producer.

Some of these xibalbines contain a characteristic structural element that is familiar from other toxins, especially those produced by spiders: several amino acids (cysteines) of the peptide are bound to each other in such a manner that they form a knot-like structure.

This in turn makes the peptides resistant to enzymes, heat and extreme pH values. Such knottins often act as neurotoxins, interacting with ion channels and paralysing prey – an effect that has also been proposed for some xibalbines.

The study shows that all the xibalbine peptides tested by the co-operation partners’ doctoral students – and in particular Xib1, Xib2 and Xib13 – effectively inhibit potassium channels in mammalian systems.

Von Reumont said: “This inhibition is greatly important when it comes to developing drugs for a range of neurological diseases, including epilepsy.”

Xib1 and Xib13 also exhibit the ability to inhibit voltage-gated sodium channels, such as those found in nerve or heart muscle cells.

In addition, in the sensory neurons of higher mammals, the two peptides can activate two proteins – kinases PKA-II and ERK1/ 2 – involved in signal transduction.

The latter suggests that they are involved in pain sensitization, which opens up new approaches in pain therapy.

Although the xibalbines’ bioactivity is exemplary of the untapped potential of marine biodiversity, the production of drugs from animal venoms is a complex and time-consuming process.

Von Reumont said: “Finding suitable candidates and comprehensively characterizing their effects, thus laying the foundation for safe and effective drugs, is only possible today in a large interdisciplinary team, as in the case of our study.”

Cenotes were once sacred to the Maya, as the karst caves were considered the entrance to the divine underworld. Credit: Björn M von Reumont.

Under threat

Making matters more difficult is the fact that time is of the essence for the remipedes.

Their habitat is under serious threat from the construction of the Tren Maya intercity railroad network, which cuts straight through the Yucatan Peninsula.

Von Reumont, who, as an experienced cave diver, has collected remipedes in Yucatan during several cave diving expeditions, explained: “The cenotes are a highly sensitive ecosystem.

“Our study highlights the importance of protecting biodiversity, not only for its ecological significance, but also for potential substances that could be of crucial importance to us humans.”

The study is published in BMC Biology.

Share This…

Today’s Science – Tomorrow’s Scientists

ABOUT US

ScienceVega and its accompanying website, sciencevega.com, exist to bring today’s science to tomorrow’s scientists. And it will do this in a way which is completely free to both school and pupil. The pathway from GCSE to A-level to degree to scientific career is not always obvious. Quite often it is ambiguous and not enough is done to show a fourteen-year-old the possibilities open to them in a decade’s time.

Many may harbour the vague idea of ‘saving the whales’, but how many know how to get there? How many realise that as they go along their focus might change? The draw of the ocean may remain, but how many realise that instead of studying whales, they actually add to our knowledge of disappearing corals in the Pacific Ocean? Or the marked drop off in populations of crustaceans unique to Western Australia? Or examining fish behaviours in the Indian Ocean? But those careers are there and ScienceVega will showcase them, along with the scientists, both established professors at the top of their field and young PhD scientists just starting out on their career paths.

Should you wish to advertise with us, and help this venture to continue to reach our young scientists, please contact: office@sciencevega.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.